Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

CDK-inhibitory pyrazolobenzodiazepines for cancer

Dec. 4, 2000

GEM-231 can be safely used with taxanes in advanced cancer patients according to phase I data

Dec. 1, 2000

Favorable preclinical results for huN901-DM1/BB-10901 support rapid advance to clinic

Dec. 1, 2000

CRC describes new prodrugs for cancer ADEPT or GDEPT

Dec. 1, 2000

Positive preliminary response rate reported for RSR-13 in NSCLC

Dec. 1, 2000

Bristol-Myers Squibb seeks FDA approval to begin systemic CA4P trials

Dec. 1, 2000

Abgenix and Immunex join forces for development of anticancer antibodies

Dec. 1, 2000

Scotia submits additional data to FDA for Foscan NDA

Nov. 30, 2000

U.K. scientists investigate novel series of antitumor agents

Nov. 30, 2000

Maxim receives SBIR grant for development of caspase-inducing drugs

Nov. 30, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Science
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Asia
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...